DOROTHY ROZELLE: Open Payments
NPI 1003522053 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 59 payments from 21 companies in 2025. Trend: 2023 $139 · 2024 $467 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $285 |
| W. L. Gore & Associates, Inc. | 1 | $122 |
| Biogen, Inc. | 3 | $66 |
| Impel Pharmaceuticals LLC | 3 | $65 |
| Lilly USA, LLC | 3 | $58 |
| Eisai Inc. | 3 | $54 |
| Janssen Biotech, Inc. | 2 | $48 |
| Genentech USA, Inc. | 2 | $47 |
| Alexion Pharmaceuticals, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $35 |
Products named: BOTOX, GORE CARDIOFORM Septal Occluder, UBRELVY, QULIPTA, TYSABRI, TRUDHESA, AMYVID, Leqembi.
Industry payments across NJ — which companies pay providers there.
